Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Archives of Dermatological Research|January 1, 1990
Dexamethasone-induced plasminogen activator inhibitor: characterization, purification, and preparation of monoclonal antibodiesA Oikarinen, M Höyhtyä, M Järvinen
Breast Cancer Research and Treatment|January 1, 1993
Type IV collagenases in invasive tumorsK Tryggvason, M Höyhtyä, C Pyke
Anticancer Research|May 16, 2000
Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic markerS Ylisirniö, M Höyhtyä, T Turpeenniemi-Hujanen
The American Journal of Pathology|November 1, 1996
Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritisS T Nikkari, M Höyhtyä, J Isola, et al.
Equine Veterinary Journal. Supplement|October 31, 2002
Effect of exercise on plasma ferritin concentrations: implications for the measurement of iron statusS Hyyppä, M Höyhtyä, M Nevalainen, et al.
Clinical & Experimental Metastasis|May 1, 1997
Ovarian cancer cell invasion is inhibited by paclitaxelA Westerlund, E Hujanen, M Höyhtyä, et al.
British Journal of Cancer|January 1, 1997
Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stageP Ring, K Johansson, M Höyhtyä, et al.
Anticancer Research|May 16, 2000
Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancerA Oberg, M Höyhtyä, B Tavelin, et al.
Clinical Chemistry|January 1, 1987
High-affinity monoclonal antibodies specific for human prostatic acid phosphataseM Höyhtyä, P Vihko, L Vuolas, et al.
Gynecologic Oncology|September 30, 1999
Gelatinase A-immunoreactive protein in ovarian lesions- prognostic value in epithelial ovarian cancerA Westerlund, M Apaja-Sarkkinen, M Höyhtyä, et al.
Pageof 5